Lexicon Pharmaceuticals
Clinical trials sponsored by Lexicon Pharmaceuticals, explained in plain language.
-
New hope for diabetic nerve pain: experimental drug tested in 496 patients
Symptom relief CompletedThis study tested an experimental drug called LX9211 to see if it can reduce nerve pain caused by diabetes. About 496 adults with diabetic peripheral neuropathic pain took either the drug or a placebo for 8 weeks. The main goal was to measure changes in daily pain scores and how …
Phase: PHASE2 • Sponsor: Lexicon Pharmaceuticals • Aim: Symptom relief
Last updated May 19, 2026 12:01 UTC
-
New drug aims to ease lingering shingles nerve pain
Symptom relief CompletedThis study tested an experimental drug called LX9211 to see if it can reduce pain caused by postherpetic neuralgia, a nerve pain that continues after a shingles rash heals. The trial involved 79 adults with moderate to severe pain lasting at least 3 months. Participants received …
Phase: PHASE2 • Sponsor: Lexicon Pharmaceuticals • Aim: Symptom relief
Last updated May 18, 2026 12:12 UTC